Choksi Laboratories Limited has officially communicated to the Bombay Stock Exchange (BSE) regarding its non-applicability under SEBI's framework for fund raising through debt securities by large entities. The company confirmed on April 15, 2026, that it does not meet the criteria for 'Large Corporate' classification under the regulatory framework.

Regulatory Framework Details

The communication references multiple regulatory documents that govern debt securities issuance by large entities:

Compliance Confirmation

The company has confirmed that since it does not fall under the 'Large Corporate' category as per the SEBI framework, the requirement of filing Annual Disclosure in Annexure B2 for the year ended March 31, 2026 does not apply. This exemption relieves the company from specific disclosure obligations mandated for larger entities in the debt securities space.

Corporate Communication

The formal communication was signed by Prakhar Dubey, Company Secretary and Compliance Officer, and submitted to BSE for record-keeping and publication on the exchange's website for investor information. The company has requested BSE to take the information on record and make it available to investors and members through the exchange's official website.

Company Information

This regulatory compliance confirmation ensures transparency with stakeholders regarding the company's obligations under SEBI's debt securities framework and clarifies its current status vis-à-vis large corporate classification requirements.

Choksi laboratories Limited has submitted its compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st March 2026. The pharmaceutical company filed the mandatory certificate with BSE Limited on 07-04-2026, ensuring adherence to regulatory requirements for securities dematerialisation processes.

Regulatory Compliance Details

The compliance certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), which serves as the company's registrar and share transfer agent. The certificate confirms that all securities received from depository participants for dematerialisation during Q4FY26 were properly processed within prescribed timelines.

Certificate Confirmation

MUFG Intime India confirmed that securities received from depository participants during the quarter were appropriately accepted or rejected to the depositories. The registrar verified that all security certificates received for dematerialisation were properly mutilated and cancelled after due verification by depository participants.

Key confirmations included in the certificate:

• Securities were confirmed to depositories within prescribed timelines
• Security certificates comprised in dematerialisation were listed on relevant stock exchanges
• Names of depositories were substituted in the register of members as registered owners
• All processes followed regulatory guidelines for dematerialisation

Corporate Information

Choksi Laboratories Limited operates from its corporate office and central laboratory located at Survey No 9/1, Near Tulsiyana Industrial Park, Gram Kumerdi, Indore. The company secretary and compliance officer Prakhar Dubey signed the submission to BSE Limited, ensuring proper documentation of the regulatory compliance.

The submission reflects the company's commitment to maintaining transparency and adhering to SEBI regulations governing depositories and participants. This quarterly compliance certificate is a mandatory requirement under SEBI regulations to ensure proper handling of securities dematerialisation processes.